Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar + DE in Neoadjuvant Breast Cancer
NCT01479036Phase 3Unknown
- Sponsor
- Xijing Hospital
- Start
- Oct 2011
- Primary completion
- Dec 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in breast cancer, sponsored by Xijing Hospital. Status: unknown.
02
Drugs
endostar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01479036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479036.